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Background: Insulin-like growth factor-I (IGF-I) shares a high 
degree of structural and functional homology with insulin 
and is a potent mitogen supporting cell growth and survival 
in many kinds of the tissues and cells. It also plays a role in 
some differentiation and anti-apoptotic functions. In previ-
ous reports, it has been shown that IGF-I stimulates hair 
follicle (HF) growth, maintains the anagen stage, and post-
pones the catagen stage. Objective: The exact mechanism of 
the effect of IGF-I on HF growth is not yet established. 
Therefore, we investigated the relationships between IGF-I 
and various other factors (i.e. apoptosis related molecules, 
pro-inflammatory cytokines, other growth factors, etc.) in the 
control of HF growth. Methods: The effect of IGF-I on human 
hair growth was measured using an organ culture model of 
human HFs and compared with a control group that did not 
receive IGF-I. We also measured mRNA expression of factors 
related to hair growth and apoptosis (which was determined 
by reverse transcription polymerase chain reaction 
(RT-PCR). RT-PCR was done on days 2, 4, 6, and 8 of organ 
culture. Results: In organ cultured human hair follicles, IGF-I 
had a positive effect on the rate of linear hair growth. IGF-I 
maintained the anagen phase. IGF-I increased the expression 
of platelet-derived growth factor (PDGF)-A, PDGF-B and the 
expression ratio of Bcl-2/Bax. Conclusion: The effect of IGF-I 
on hair growth appears to be related to the upregulation of 
PDGF-A and PDGF-B and to the anti-apoptotic effect of IGF-I. 
(Ann Dermatol 24(1) 26∼31, 2012)
-Keywords-
Hair growth, IGF-I, PDGF-A, PDGF-B
INTRODUCTION
Insulin-like growth factor-I (IGF-I) is a growth factor with 
sequence homology to pro-insulin. It has been identified 
as an important growth factor in many biological systems
1. 
IGF-I is critically involved in promoting hair growth by 
regulating cellular proliferation and migration during the 
development of hair follicles (HFs)
2. The proliferating fun-
ction of IGF-I in skin may be important to the develop-
ment of HFs. Transgenic mice overexpressing IGF-I in the 
skin have earlier HF development
3. IGF-I receptor knock-
out mice have fewer, smaller and earlier HF development
4. 
Itami and Inui
5 demonstrated that IGF-I is produced by 
dermal papilla cells. Since IGF-I receptors were detected 
in keratinocytes, it is possible that IGF-I produced by 
dermal papilla cells might act on keratinocytes, thereby 
promoting hair growth through stimulation of the prolife-
ration of keratinocytes in the HFs
6.
To exert its biological effects, IGF-I must activate cells by 
binding to specific cell-surface receptors. The type I IGF 
receptor (IGF-IR) is the only IGF receptor to have IGF- 
mediated signaling functions
1. In tissues, IGF-I is produced 
by mesenchymal type cells and acts in a paracrine fashion 
and /or an autocrine fashion by binding to the IGF-IR. This Effect of IGF-I on Hair Growth is Related to IGF-I and Up-regulation of PDGF-A and PDGF-B
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binding activates the receptor tyrosine kinase that triggers 
the downstream responses and finally stimulates cell divi-
sion
7. IGF-I may therefore be able to stimulate the prolife-
ration of HF cells through cellular signaling pathways of 
its receptors. 
The growth of hair is a cyclic process in which every 
follicle proceeds from an active phase (anagen) through a 
regression phase (catagen) to a resting phase (telogen). 
During catagen, HFs undergo apoptosis and there is a 
decline in an apoptotic protein, Bcl-2, and an increase in a 
pro-apoptotic protein, Bax
8. In several reports, IGF-I and 
IGF-II have prevented the follicle from developing catagen- 
like status
9.
In many experimental reports, pro-inflammatory cytokines, 
such as IL-1α,β, TNF-α, and INF-γ, have been reported 
to induce apoptosis of hair bulb keratinocytes
10-12.
Platelet-derived growth factor (PDGF) is a potent mitogen 
produced in a variety of cell types including keratinocytes 
and endothelial cells, and is important for cell growth. 
Expression of PDGF isoforms in HFs in vitro can be 
influenced by treatment with cytokines that are known to 
be positive and negative regulators of HF growth activity
13. 
Recently, PDGF also induced and maintained anagen 
phase in mouse hair cycling
14. The effects of PDGF on 
HFs, that is induction and maintenance of anagen, is very 
similar to the effect of IGF-I on hair growth. 
In the current study, expression of hair growth factors & 
cytokines (PDGF-A, PDGF-B, transforming growth factor 
[TGF]-β, interleukin [IL]-1α, IL-1β, tumor necrosis factor 
[TNF]-α , interferon [INF]-γ ) and apoptosis-related molecules 
(Bax, Bcl-2, c-myc) were determined by reverse trans-
cription polymerase chain reaction (RT-PCR), after treat-
ment of cells with IGF-I using an organ culture model of 
human HFs. This experiment was done in order to 
examine the molecular mechanism underlying the effect 
of IGF-I on HFs.
MATERIALS AND METHODS
Specimens 
Human occipital scalp skin specimens were obtained from 
hair transplantation surgery, after informed consent. The 
medical ethical committee of the Yonsei University Wonju 
College of Medicine, Wonju, Korea, approved all descri-
bed studies. The study was conducted according to the 
Declaration of Helsinki principles. Skin samples, used for 
HF microdissection and organ culture, were collected and 
stored in a refrigerator at 4
oC.
Isolation and culturing of human HFs
Human HFs in the Anagen VI stage were isolated as 
previously described
15. Briefly, after separation of epider-
mis and dermis from the dermo-subcutaneous interface, 
anagen HFs were isolated from subcutaneous fat under a 
binocular microscope with watchmaker’s forceps. The 
total number of HFs used in this study was 140, derived 
from 3 different individuals. Each one of the anagen HFs 
was carefully transferred to a per well of a 24-well plate 
(Corning Incorporated, Corning, NY, USA). In the control 
group, isolated anagen HFs were maintained in 500 ul of 
William’s E medium (Gibco BRL, Gaithersburg, MD, USA) 
supplemented with 10 ng/ml hydrocortisone (Sigma, St. 
Louis, MO, USA), 2 mM L-glutamine (Gibco BRL), 100 
IU/ml penicillin and 100 ug/ml streptomycin (Gibco BRL) 
and without insulin. In the IGF-I group anagen HFs were 
incubated under the same conditions. The only difference 
was that 10
－7 M IGF-I was added to the experimental 
group.
HFs were maintained free-floating at 37
oC in an atmos-
phere of 5% CO2 and 95% air in a humidified incubator. 
At least 20 HFs were cultured in each type of medium. 
Briefly, control HFs were cultured with vehicle for 12 
days. The culture medium was changed every 2 days and 
the follicles were cultivated in the culture medium as they 
were suspended freely. The same experiment was repea-
ted three times.
Measurement of shape and growth in follicle length
For measurement of follicle length, the entire length from 
the base of the hair bulb to the tip of the hair shaft was 
measured using the measuring scales attached to the 
objective lens of the microscope. This was done until the 
12
th day of cultivation in 2 day intervals, and the results 
were statistically analyzed. At the same time, follicle 
shapes (anagen phase, catagen phase, telogen phase) were 
observed and the duration of anagen phase for each 
follicle was examined. 
Semi-quantitative RT-PCR analysis
Total RNA was extracted from isolated human anagen VI 
stage HFs using a monophasic solution of phenol and 
guanidine isothiocyanate (TRIzol Reagent; Gibco BRL). 
The concentration of RNA was determined using a UV 
spectrometer at 260 nm. Aliquots (1.0 ug) of RNA were 
reverse transcribed using Moloney murine leukemia virus 
reverse transcriptase (MML-V RTase, Promega, Madison, 
WI, USA). Briefly, RNA samples were incubated at 70
oC 
for 10 minutes with molecular biology grade water. After 
chilling on ice, primer extension and reverse transcription S Y  A h n ,  e t  a l
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Table 1. Primer sequences
Primer Forward Reverse
 GAPDH  GAAGGTGAAGGTCGGAGT  GAAGATGGTGATGGGATTTC
 IL-1α   GTCTCTGAATCAGAAATCCTTCTATC  CATGTCAAATTTCACTGCTTCATC
 IL-1β   CAGCCATGGCAGAAGTACCT  GACATCACCAAGCTTTTTTGC
 INF-r  ATGAAATATACAAGTTATATCTTGGCT   ACTGGGATGCTCTTCGACCTCGA 
 TNF-α  CCCGAGTGACAAGCCTGTAG  GATGGCAGAGAGGAGGTTGAC
 TGF-β   ACCGCCGCACAACTCCGGTGAC  ATCTATGACAAGTTCAAGCAGAGTA
 C-myc  GAGGCGAACACACAACGTCTT  CGCAACAAGTCCTCTTCAGAAA
 Bax  ACCAAGAA GCTGAGCGAGTGTC  TGTCCAGCCCATGATGGTTC
 BCL-2  CGACGACTTCTCCCGCCGCTACCGC  CCGCATGCTGGGGCCGTACAGTTCC
 PDGF-A  GCCCATTCGGAGGAAGAG  TTGGCCACCTTGACGCTGCG
 PDGF-B  GAAGGAGCCTGGGTTCCCTG  TTTCTCACCTGGACAGGTCG
GAPDH: glyceraldehyde-3-phosphate dehydrogenase, IL: interleukin, INF: interferon, TNF: tumor necrosis factor, TGF: transforming 
growth factor, PDGF: platelet-derived growth factor.
Fig. 1. Quantitative analysis of hair shaft average elongation. Hair
follicles were incubated in the presence or absence of insulin-like
growth factor-I (IGF-I) for 12 days. The length of the hair follicles
was measured in 2 day interval. The hair shaft average elongation
of IGF-I group showed more greater compared to control group.
This tendency was most prominent at 2nd days. Data are based
on 24 hair follicles per group, and presented as the mean±SEM.
*p＜0.05. 
Fig. 2. Effect of insulin-like growth factor-I (IGF-l) on cumulative
hair follicle elongation for 12 days: The difference between two
group was firstly identified at 2nd day of experiment. All day 
of experiment showed a statistical significance. *p<0.05.
were done by the addition of 1X RT-buffer, 5 mM MgCl2 
Solution, 1 mM deoxynucleotide triphosphates, 2.5 uM 
Oligo d(T)16 (Roche Molecular Biochemicals,. Indianapolis, 
IN, USA) and MML-V RTase (2.5 units/ul) in 20 ul reaction 
volumes. Samples were then incubated at 42
oC for 45 
minutes before storage at －20
oC. One ul cDNA was then 
subjected to PCR cycles as follows: a 95
oC denaturation 
phase for 5 minutes, followed by 35 cycles of 95
oC for 1 
min, 60
oC for 1 minute, 72
oC for 1 min; and an additional 
extension for 10 min at 72
oC. The primers used for ampli-
fying the respective fragments are listed in Table 1. The 
PCR product was visualized on a 2% agarose gel.
Statistical analysis
The results are expressed as mean±SD, The t-test was 
used for analyzing differences between two groups. Data 
handing and plotting were processed by the Statistical 
Package for the Social Sciences (SPSS) for Windows 
statistical package (SPSS Inc., Chicago, IL, USA). 
RESULTS
Effect of IGF-1 on cumulative human HF elongation 
over 12 days
Grossly, the IGF-1 treated group showed more remarkable 
hair growth (approximately 0.10 mm/day) compared with 
the control group (approximately 0.08 mm/day). 
On each experimental day, the IGF-1 group showed more 
significant hair growth than control (Fig. 1). This tendency Effect of IGF-I on Hair Growth is Related to IGF-I and Up-regulation of PDGF-A and PDGF-B
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Fig. 3. (A) In both group, until 4th day, all hair follicle remain anagen stage. on the 8th day, control group hair follicles showed
more dermal papillae shrinkage than control group. (B) Insulin-like growth factor-I (IGF-I) treated group showed more anagen proportion
from 6th day to 12th day of experiment.
was most prominent during the second day of the 
experiment, with the results showing notable numerical 
differences between the two groups (Fig. 1). There was a 
significant difference (p＜0.05) in cumulative HF elonga-
tion between the control group (0.97±0.09 mm) and the 
10
－7 M IGF-1 treated HFs (1.24±0.09 mm) (Fig. 2).
Proportion of anagen HFs in control and experimental 
groups
Both experimental and control groups consisted of 24 
anagen hairs. Until the 4th day of the experiment, in both 
groups, all HFs remained in the anagen hair stage (24/24). 
On the 6th day, a difference in the anagen proportion was 
found. The IGF-I treated group showed more anagen HFs 
(21/24) than controls (17/24). The IGF-I group showed a 
larger anagen proportion from the 6th to the 12th day. On 
the 8th and 10th days, the control group showed eleven 
anagen HFs (11/24) and the IGF-I group showed seven-
teen anagen HFs (17/24).
On the 12th day, the control group showed 45.8% anagen 
HFs (11/24) and the IGF-I group showed 70.8% anagen 
HFs (17/24) (Fig. 3).
Change in the expression by HFs of hair growth related 
factors 
Increasing evidence suggests that several factors, such as 
cytokine and apoptosis related molecules, are involved in 
the hair growth cycle
15-18. In this study, semi-quantitative 
RT-PCR analysis was used to search for factors that were 
affected by IGF-I. We measured expression levels of 
PDGF-A (platelet derived growth factor-A), PDGF-B, TGF-
β, IL-1α, IL-1β, TNF-α, INF-γ, and apoptosis-related 
molecules (Bax, Bcl-2, c-myc). 
Pro-inflammatory cytokines such as IL-1α, IL-1β, INF-γ, 
and TNF-α are known to promote the apoptosis of folli-
cular keratinocytes. In both the experimental and the con-
trol groups, baseline differences in these pro-inflammatory 
cytokines were insignificant, as was TGF-β. However, on 
the 2nd day, there was a significant difference in PDGF-A 
& B expression between the two groups. On the 2nd day, 
the IGF-I treated group showed more prominent expres-
sion of PDGF-A, and PDGF-B also showed a significant 
increase in expression. Among the apoptosis related 
molecules, Bax and Bcl-2 showed differences in expres-
sion. On the 8th day, Bax was weakly expressed in the 
IGF-I treated group. On the 2nd day, Bcl-2 was more 
strongly expressed in the IGF-I treated group compared 
with the control group. Another apoptosis related mole-
cule, c-myc, did not show a significant difference in 
expression (Fig. 4).
DISCUSSION
The HF is a cutaneous organ that shows cyclic activity in 
postnatal life and transits through periods of active hair 
growth (anagen), apoptosis-driven involution (catagen), hair 
shedding (exogen), and relative rest (telogen)
14. During HF 
growth and hair production, the activity of factors promo-
ting the proliferation, differentiation, and survival predo-
minates, whereas HF regression is characterized by the S Y  A h n ,  e t  a l
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Fig. 4. Results of reverse transcription polymerase chain reaction: IL-1α, IL-1β, INF-γ, TNF-α and TGF-β, did not show significant
difference of their expression between two groups. But at 2 day of experiment, insulin-like growth factor-I (IGF-I) treated group show 
more prominent expression of PDGF-A & PDGF-B. Among the apoptosis related molecules, in 8th day, Bax was more weakly expressed,
in IGF-I treated group and Bcl-2 showed more strongly expressed in second day of experiment. GAPDH: glyceraldehyde-3-phosphate
dehydrogenase, IL: interleukin, TNF: tumor necrosis factor, INF: interferon, TGF: transforming growth factor, PDGF: platelet-derived 
growth factor.
activation of a variety of signaling pathways that induce 
apoptosis in HF cells
8,15.
IGF-I is known as an important growth factor in many 
biological systems and it has also been shown to play a 
critical role in promotion of hair growth
19,20. Since IGF-I 
receptor mRNA was detected in keratinocytes
14, it is 
possible that IGF-I produced by dermal papilla cells acts 
on keratinocytes, thereby promoting hair growth through 
stimulation of the proliferation of keratinocytes in HFs
20. 
In several reports, IGF-I and IGF-II prevented the follicle 
from developing catagen like status
9.
In this study, we showed that IGF-I has a significant effect 
on the rate of linear hair growth and extended the overall 
anagen phase, making it longer than that of the control 
group. On the 2nd day, both the IGF-I treated group and 
the control group showed the most significant growth. We 
also demonstrated that these growth patterns are correla-
ted with the molecular findings - the expression of PDGF- 
A and PDGF-B were remarkably increased compared to 
control and the expression of Bcl-2/bax ratio was higher 
than control on the 2nd day. According to Tomita et al.
14, 
PDGF-A and PDGF-B induced and maintained the anagen 
phase of murine HFs. These effects were very similar to 
effects of IGF-I on hair growth.
Anti-apoptotic molecules have a critical role in hair cycles. 
For example, bcl-2 was found in the dermal papilla 
throughout the murine hair cycle, but its expression in the 
follicular epithelium increases in anagen, decreases in 
catagen and disappears in telogen
21. Lindner et al.
8 also 
demonstrated that during catagen, follicle cells in the bulb 
region undergo apoptosis and this is correlated with a 
down-regulation of bcl-2, while these apoptotic processes 
do not occur in the dermal papilla. It was believed that 
changes in the expression level of bcl-2 genes before 
catagen may be the signals for inducing apoptosis, while 
their reduced expression during catagen may be due to 
the apoptotic process
22.
Regulation of bcl-2 through IGF signaling pathways have 
been studied in other cell types. For example, apoptosis 
prevented by IGF-I in promyeloid cells during aging was 
reported to be associated with activation of phosphatidy-
linositol 3’-kinase (PI3K)
23. The latter function is correlated 
with high levels of Bcl-2
22. In this study, we also found 
that on the 2nd day of the experiment the expression of 
Bcl-2 was stronger in the IGF-I treated group than in the 
control group. On the 8th day, the expression of Bax was 
weaker in the IGF-I treated group. These changes in 
expression patterns were similar to those for PDGF-A and 
PDGF-B: both PDGF-A and B increased in the IGF-I 
treated group on the 2nd day. 
IGF-I activates two signaling pathways: 1) the extracellular 
signal related kinase/mitogen activated kinase pathway 
and 2) the phosphatidylinositol 3 kinase (PI3K)/Akt path-
way. Both are implicated in survival.Effect of IGF-I on Hair Growth is Related to IGF-I and Up-regulation of PDGF-A and PDGF-B
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In conclusion, IGF-I has a significant effect on the rate of 
linear hair growth and extended the overall anagen phase. 
As stated above, the IGF-I treated group showed a sig-
nificant difference in hair growth on the 2nd day of the 
experiment. This result was similar to the increase in ex-
pression of PDGF-A, B and the Bcl-2/Bax ratio in experi-
mental groups that took place on the 2nd day of the ex-
periment. According to these finding, we suggest that the 
effect of IGF-I on hair growth is associated with upregu-
lation of PDGF-A and PDGF-B and the anti-apoptotic 
effects of IGF-I.
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